Heart damage in mucopolysaccharidosis

Heart damage in mucopolysaccharidosis

The paper gives the data available in the literature on the current classification, genealogy, clinical manifestations, diagnosis, treatment, and prevention of mucopolysaccharidosis, one of the most common nosological entities of lysosomal storage diseases. Particular emphasis is laid on cardiovascu...

Full description

Bibliographic Details
Main Authors:	M. I. Dovgan, Yu. M. Belozerov, A. N. Semyachkina
Format:	Article
Language:	Russian
Published:	Ltd. “The National Academy of Pediatric Science and Innovation” 2016-03-01
Series:	Rossijskij Vestnik Perinatologii i Pediatrii
Subjects:	children lysosomal storage diseases mucopolysacharides cardiovascular system diagnosis treatment
Online Access:	https://www.ped-perinatology.ru/jour/article/view/252

Similar Items

Distribution of glycosaminoglycans (Mucopolysaccharides) in the axual region of the developing chick embrio
by: Kvist, Tage Nielson
Published: (2011)

Mucopolysaccharidosis type II: Enzyme Replacement Therapy Efficiency
by: Nato D. Vashakmadze, et al.
Published: (2020-02-01)

Newborn Screening for Mucopolysaccharidosis I: Moving Forward Learning from Experience
by: Lorne A. Clarke, et al.
Published: (2020-11-01)

A model of mucopolysaccharidosis type IIIB in pigs
by: Qiang Yang, et al.
Published: (2018-10-01)

Clinical characteristics and surgical history of Taiwanese patients with mucopolysaccharidosis type II: data from the Hunter Outcome Survey (HOS)
by: Hsiang-Yu Lin, et al.
Published: (2018-06-01)

A deletion of IDUA exon 10 in a family of Golden Retriever dogs with an attenuated form of mucopolysaccharidosis type I
by: Kiterie M. E. Faller, et al.
Published: (2020-09-01)

Non-Neuropathic Form of Mucopolysaccharidosis Type II: Clinical Cases
by: Nato D. Vashakmadze, et al.
Published: (2021-03-01)

Bi‐allelic VPS16 variants limit HOPS/CORVET levels and cause a mucopolysaccharidosis‐like disease
by: Kalliopi Sofou, et al.
Published: (2021-05-01)

Roentgenographic diagnosis of mucopolysaccharidosis with particular reference to Morquio syndrome
by: umesh chandra parashari, et al.
Published: (2012-02-01)

Long-term clinical course of a patient with mucopolysaccharidosis type IIIB
by: Ja Hye Kim, et al.
Published: (2016-11-01)

Progressive neurologic and somatic disease in a novel mouse model of human mucopolysaccharidosis type IIIC
by: Sara Marcó, et al.
Published: (2016-09-01)

New paradigms for the treatment of lysosomal storage diseases: targeting the endocannabinoid system as a therapeutic strategy
by: Edward H. Schuchman, et al.
Published: (2021-03-01)

Clinical, Biochemical and Molecular Characteristics of Fifteen Patients with Mucopolysaccharidosis Type II in Western Turkey
by: Havva Yazıcı, et al.
Published: (2018-03-01)

Clinical outcomes of laminoplasty for patients with lysosomal storage disease including mucopolysaccharidosis and mucolipidoses: a retrospective cohort study
by: Hidetomi Terai, et al.
Published: (2021-09-01)

Clinical outcomes in idursulfase-treated patients with mucopolysaccharidosis type II: 3-year data from the hunter outcome survey (HOS)
by: Joseph Muenzer, et al.
Published: (2017-10-01)

Mucopolysaccharidosis VII in Brazil: natural history and clinical findings
by: Roberto Giugliani, et al.
Published: (2021-05-01)

Determination of genotypic and clinical characteristics of Colombian patients with mucopolysaccharidosis IVA
by: Tapiero-Rodriguez SM, et al.
Published: (2018-04-01)

Mucopolysaccharidosis-Plus Syndrome
by: Filipp Vasilev, et al.
Published: (2020-01-01)

Birth weight in patients with mucopolysaccharidosis type II: Data from the Hunter Outcome Survey (HOS)
by: Olaf Bodamer, et al.
Published: (2017-06-01)

Direct gene transfer to the CNS prevents emergence of neurologic disease in a murine model of mucopolysaccharidosis type I
by: Daniel A. Wolf, et al.
Published: (2011-07-01)

Functional assessment of the genetic findings indicating mucopolysaccharidosis type II in the prenatal setting
by: Maria Fuller, et al.
Published: (2021-07-01)

Difficult diagnosis. Niemann - Pick disease, type C
by: L. S. Namazova-baranova, et al.
Published: (2014-12-01)

Highlights on Genomics Applications for Lysosomal Storage Diseases
by: Valentina La Cognata, et al.
Published: (2020-08-01)

The rapidly evolving view of lysosomal storage diseases
by: Giancarlo Parenti, et al.
Published: (2021-02-01)

Analysis of Mucopolysaccharidosis Type VI through Integrative Functional Metabolomics
by: Abdellah Tebani, et al.
Published: (2019-01-01)

Diagnosis and management of lysosomal storage disorders. Three key words: early, multidisciplinary, and network
by: Generoso Andria, et al.
Published: (2013-02-01)

Mucopolysaccharidosis Type II: One Hundred Years of Research, Diagnosis, and Treatment
by: Francesca D’Avanzo, et al.
Published: (2020-02-01)

Chondroitin sulfate disaccharide is a specific and sensitive biomarker for mucopolysaccharidosis type IVA
by: Sharon J. Chin, et al.
Published: (2020-09-01)

Potential Treatment of Lysosomal Storage Disease through Modulation of the Mitochondrial–Lysosomal Axis
by: Myeong Uk Kuk, et al.
Published: (2021-02-01)

Report of Four Children with Gaucher Disease and Review of Literature
by: Wajiha Maan, et al.
Published: (2016-08-01)

Pathway to diagnosis and burden of illness in mucopolysaccharidosis type VII – a European caregiver survey
by: Alexandra Morrison, et al.
Published: (2019-11-01)

Unveiling metabolic remodeling in mucopolysaccharidosis type III through integrative metabolomics and pathway analysis
by: Abdellah Tebani, et al.
Published: (2018-09-01)

Effects of gene therapy on cardiovascular symptoms of lysosomal storage diseases
by: Edina Poletto, et al.
Published: (2019-05-01)

Recommendations on clinical trial design for treatment of Mucopolysaccharidosis Type III
by: Arunabha Ghosh, et al.
Published: (2017-06-01)

Open issues in Mucopolysaccharidosis type I-Hurler
by: Rossella Parini, et al.
Published: (2017-06-01)

The Emerging Role of the Lysosome in Parkinson’s Disease
by: Alba Navarro-Romero, et al.
Published: (2020-11-01)

Deficiency of Lysosomic Acid Lipase: Clinical Recommendations for Child Health Care Delivery
by: A. A. Baranov, et al.
Published: (2016-08-01)

Targeted Metabolomic Analysis of a Mucopolysaccharidosis IIIB Mouse Model Reveals an Imbalance of Branched-Chain Amino Acid and Fatty Acid Metabolism
by: Valeria De Pasquale, et al.
Published: (2020-06-01)

Mucopolysaccharidosis IIIB and mild skeletal anomalies: coexistence of NAGLU and CYP26B1 missense variations in the same patient in a Chinese family
by: Jinliang Li, et al.
Published: (2018-04-01)

Investigation of newborns with abnormal results in a newborn screening program for four lysosomal storage diseases in Brazil
by: Heydy Bravo, et al.
Published: (2017-09-01)